re: Ann: Quarterly Report for period ending 3... I agree why stress? Afterall the ann is what we expected, no nasty suprises nor was there anything new.
It still doesnt change the fact that this company is still trading at a bargain price with so much to offer in the next 2 years.
- Forums
- ASX - By Stock
- NDO
- Ann: Quarterly Report for period ending 31 March
Ann: Quarterly Report for period ending 31 March , page-9
Featured News
Add NDO (ASX) to my watchlist
(20min delay)
|
|||||
Last
77.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 650 | 78.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
79.5¢ | 6000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 650 | 0.785 |
2 | 5650 | 0.780 |
1 | 692 | 0.775 |
1 | 10000 | 0.760 |
1 | 20000 | 0.755 |
Price($) | Vol. | No. |
---|---|---|
0.795 | 6000 | 1 |
0.800 | 10000 | 1 |
0.805 | 2000 | 1 |
0.810 | 7680 | 1 |
0.900 | 15000 | 1 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
NDO (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online